Publication & Citation Trends
Most Cited Works
Publications
65 total
A deep learning method for optimizing semantic segmentation accuracy of remote sensing images based on improved UNet PDF
Cited by 79
OpenAlex
<i>ZmSPL13</i>and<i>ZmSPL29</i>act together to promote vegetative and reproductive transition in maize PDF
Cited by 29
OpenAlex
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6 PDF
Cited by 92
OpenAlex
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer PDF
Cited by 45
OpenAlex
Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study
Cited by 38
OpenAlex
Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non–small-cell Lung Cancer PDF
Cited by 56
OpenAlex
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
Cited by 1,966
OpenAlex
LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) versus gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFR M+) advanced adenocarcinoma of the lung.
Cited by 83
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(26)
Lung Cancer Research Studies
(19)
Colorectal Cancer Treatments and Studies
(7)
Gastric Cancer Management and Outcomes
(5)
Neuroendocrine Tumor Research Advances
(5)
Frequent Co-Authors
Affiliations
Qingdao University
University of Science and Technology of China
Verizon (United States)
Sun Yat-sen University
Biocon (Switzerland)